NextCureÂ Inc (NXTC) Financials

$7.35

$0.55 (8.09%)

As on 02-Sep-2026 16:00EDT

Market cap

$28 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

2.3

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	--	--	--	--	--	--
Cost of Revenue	0.65	2.19	2.87	3.68	4.48	4.30
Gross Profit	-0.65	-2.19	-2.87	-3.68	-4.48	-4.30
Operating Expenses	43.62	55.43	59.75	67.64	75.91	70.77
Operating Profit (EBIT)	-43.90	-57.62	-59.75	-67.64	-75.91	-70.77
Other Income	--	--	--	--	1.18	1.38
Profit before Tax	-42.75	-55.84	-55.65	-62.72	-74.73	-69.39
Provision for Tax	--	--	--	--	-5.30	6.96
Profit after Tax (Net Income)	-42.75	-55.84	-55.65	-62.72	-69.43	-69.39
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-74.73	-69.39

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	12.15	34.94	65.47	114.42	167.53	233.39
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	4.06	4.67	5.81	6.73	7.50	2.39
Current Liabilities	6.41	10.57	9.57	6.88	9.13	6.61
Total Liabilities	29.03	50.18	80.86	128.04	184.16	242.39

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	0.37	6.44	9.05	15.31	20.18	14.57
Current Assets	22.26	43.75	71.81	112.73	163.98	227.82
Total Assets	29.03	50.18	80.86	128.04	184.16	242.39
Total Debt*	4.29	5.15	5.95	6.61	7.12	--
Net Current Assets	15.84	33.18	62.23	105.84	154.86	221.21

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-49.61	-40.81	-52.97	-53.89	-57.24
Cash Flow from Investing Activities	--	25.56	55.31	39.27	67.98	36.60
Cash from Financing Activities	--	22.31	0.14	0.15	0.20	-3.27
Net Cash Inflow / Outflow	--	--	--	--	14.29	-23.91

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-10.59	-15.93	-23.85	-26.97	-30.00	-30.12
Cash EPS ($)	--	-15.31	-22.62	-25.31	-28.22	-27.00
Adjusted Book Value ($)	--	9.97	28.05	49.20	72.38	101.32
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-14.15	-17.48	-22.78	-23.28	-24.85
Free Cash Flow per Share ($)	--	-14.15	-17.69	-23.13	-24.20	-25.88

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-100.15	-57.84	-42.43	-34.03	-26.16
ROE (%)	-181.55	-111.23	-61.87	-44.49	-34.64	-26.33
ROA (%)	-97.71	-85.23	-53.28	-40.18	-32.56	-25.28
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	--	--	--	--	-5,904.17	-5,042.81
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	--	--	--	--	--	-1.00
EBIT Growth (%)	54.28	2.38	8.80	17.37	-9.52	-68.13
Net Profit Growth (%)	29.84	-0.34	11.27	9.66	-0.06	-109.07
EPS Growth (%)	59.14	0.33	0.12	0.10	0.00	-1.09
Book Value Growth (%)	-82.83	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-0.89	-0.03	-0.04	-0.05	-0.20
Price / Book Value	2.27	1.42	0.03	0.02	0.02	0.06
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	0.51	-0.24	1.12	1.68	2.08	3.16
Close Price ($)	1.60	14.19	9.25	13.68	16.92	72.00
High Price ($)	67.41	67.41	30.84	23.04	77.76	172.80
Low Price ($)	1.55	2.80	9.12	11.76	13.92	66.36
Market Cap ($ Cr)	27.88	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.15	0.09	0.06	0.04	--
Short term debt to equity ratio	0.06	0.03	0.01	0.01	0.00	--
Current Ratio	3.47	4.14	7.50	16.38	17.97	34.48
Quick Ratio	3.47	--	--	--	18.04	--
Interest Coverage	--	--	--	--	-14.32	-900.16

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	-69.40	-57.07	--
Payable days	--	615.49	489.74	327.18	253.23	248.16
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.